Eagle Pharmaceuticals, Inc. (EGRX)
0.90
-0.05
(-5.26%)
USD |
OTCM |
Nov 06, 16:00
Eagle Pharmaceuticals Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 0.0468 |
| November 05, 2026 | 0.0494 |
| November 04, 2026 | 0.0494 |
| November 03, 2026 | 0.0494 |
| November 02, 2026 | 0.0494 |
| October 30, 2026 | 0.0494 |
| October 29, 2026 | 0.0494 |
| October 28, 2026 | 0.0494 |
| October 27, 2026 | 0.0494 |
| October 26, 2026 | 0.0494 |
| October 23, 2026 | 0.052 |
| October 22, 2026 | 0.052 |
| October 21, 2026 | 0.2044 |
| October 20, 2026 | 0.046 |
| October 19, 2026 | 0.046 |
| October 16, 2026 | 0.046 |
| October 15, 2026 | 0.0457 |
| October 14, 2026 | 0.0457 |
| October 13, 2026 | 0.046 |
| October 12, 2026 | 0.0504 |
| October 09, 2026 | 0.0504 |
| October 08, 2026 | 0.0504 |
| October 07, 2026 | 0.0504 |
| October 06, 2026 | 0.0504 |
| October 05, 2026 | 0.0504 |
| Date | Value |
|---|---|
| October 02, 2026 | 0.0504 |
| October 01, 2026 | 0.0499 |
| September 30, 2026 | 0.0494 |
| September 29, 2026 | 0.0533 |
| September 28, 2026 | 0.0533 |
| September 25, 2026 | 0.0533 |
| September 24, 2026 | 0.0468 |
| September 23, 2026 | 0.0468 |
| September 22, 2026 | 0.0468 |
| September 21, 2026 | 0.0468 |
| September 18, 2026 | 0.0668 |
| September 17, 2026 | 0.0668 |
| September 16, 2026 | 0.0668 |
| September 15, 2026 | 0.0668 |
| September 14, 2026 | 0.0668 |
| September 11, 2026 | 0.0084 |
| September 10, 2026 | 0.0392 |
| September 09, 2026 | 0.039 |
| September 08, 2026 | 0.039 |
| September 04, 2026 | 0.039 |
| September 03, 2026 | 0.039 |
| September 02, 2026 | 0.0475 |
| September 01, 2026 | 0.0481 |
| August 31, 2026 | 0.0481 |
| August 28, 2026 | 0.0481 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.644 |
| Alnylam Pharmaceuticals, Inc. | 5.793 |
| Anika Therapeutics, Inc. | 1.416 |
| Savara, Inc. | 6.906 |
| Vericel Corp. | 7.257 |
Price to Book Value Related Metrics
| Price | 0.90 |
| Market Cap | 11.79M |